What’s New in the Treatment and Management of Thyroid Cancer?

August 22, 2017
Greg Guthrie, ASCO staff

The 3rd World Congress on Thyroid Cancer was held July 27 to 30 in Boston, Massachusetts. This scientific meeting brings together experts in the treatment and management of thyroid cancer from all over the world.share on twitter

In this podcast, Ezra E.W. Cohen, MD, FRCPC, FASCO, describes some of the key themes from the meeting:

  • Genetic analysis plays a bigger role in the initial diagnosis of thyroid cancer. [1:51]

  • How surgery is used to treat early thyroid cancer. [2:32]

  • What medical treatment of advanced disease involves, including using similar drugs in sequence to control the cancer and adding a second drug to the treatment plan that works differently. [3:05]

  • How specific genetic changes, or mutations, can be treated with targeted therapy, specifically BRAF or NTRK inhibitors. [4:49]

  • The future of immunotherapy in the treatment and management of thyroid cancer. [5:43]

Dr. Cohen is the Cancer.Net Associate Editor for head and neck cancer. He is the Associate Director of Translational Science at Moores Cancer Center at UC San Diego Health and leads the Solid Tumor Research Program there.

This is a prerecorded audio podcast. It can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.

Share your thoughts on this blog post on Cancer.Net's Facebook and Twitter.